Next Article in Journal
Molecular Characterization of Arabinoxylans from Hull-Less Barley Milling Fractions
Next Article in Special Issue
The Effects of Co-Treatment of 9-cis-Retinoic Acid and 15-Deoxy-Δ (12,14)-prostaglandin J2 on Microglial Activation
Previous Article in Journal
Glycosides, Depression and Suicidal Behaviour: The Role of Glycoside-Linked Proteins
Previous Article in Special Issue
Analgesic-like Activity of Essential Oils Constituents
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Essential Oils and Their Constituents: Anticonvulsant Activity

1
Laboratório de Tecnologia Farmacêutica, Federal University of Paraíba, Caixa Postal 5009, CEP 58051-970, João Pessoa, PB, Brazil
2
Department of Physiology, Federal University of Sergipe, CEP 49100-000 São Cristóvão, SE, Brazil
*
Author to whom correspondence should be addressed.
Molecules 2011, 16(3), 2726-2742; https://doi.org/10.3390/molecules16032726
Submission received: 13 December 2010 / Revised: 18 March 2011 / Accepted: 22 March 2011 / Published: 23 March 2011
(This article belongs to the Special Issue Neuroactive Compounds)

Abstract

:
A literature-based survey of plants species and their essential oils with anticonvulsant activity was carried out. As results, 30 species belonging to 13 families and 23 genera were identified for their activities in the experimental models used for anticonvulsant drug screening. Thirty chemical constituents of essential oils with anticonvulsant properties were described. Information on these 30 species is presented together with isolated bioactive compound studies.

1. Introduction

According to the WHO [1], about 450 million people in the entire world have suffered mental, neurological, or behavioral problems at some time in their life. Extensive research on plants and their derivatives has taken place in recent years that could provide some new alternative treatments and therapeutic uses for diseases of the central nervous system (CNS).
Epilepsy is the term used for a group of disorders characterized by recurrent spontaneous seizures that apparently result from complex processes involving several neurotransmitter systems such the glutamatergic, cholinergic, and gabaergic system. Actual estimations of the prevalence rate for epilepsy are 1–2% of the world population. Although a considerable number of classic and more modern anticonvulsant drugs are available for the pharmacological treatment of epilepsy patients worldwide, seizures remain refractory in more than 20% of the cases. In addition, all current antiepileptic drugs, which belong to several quite different chemical classes such as hydantoins, deoxybarbiturates, succinimides, benzodiazepines, iminostilbenes and carboxylic acids, have been obtained through chemical synthesis [2].
Several species of aromatic plants are used medicinally because of their volatile oils or chemical components. In particular, some of them possess certain CNS properties, including antiepileptic action and have been traditionally used for a long time in folk medicine. Recent studies on essential oils and their main components have attracted the attention of many scientists and encouraged them to screen any of these natural products to study their chemical and pharmacological aspects that might potentially may lead to lead to the development of new anticonvulsant-like compounds with advantages over current therapeutic drugs [3].

1.1. Chemistry of Essential Oils and Main Chemical Constituents

Aromatic plants are at present widely studied for their large therapeutic potential and benefits. These benefits depend largely on essential oils which, in general terms, occur in many herbs. The essential oils of the plant are the essence of their fragrance. They are called essential oils, ethereal oils, or volatile oils because they evaporate quickly when exposed to the air at ordinary temperatures. In general, the essential oils consist of chemical mixtures involving several tens to hundreds of different types of molecules. Only a few have a high percentage of a single component. These chemical constituents are divided into two broad classes: terpenes and phenylpropanoids. However, many volatile oils consist largely of monoterpenes, which are a group of terpenes having ten carbon atoms in the carbon skeleton and, therefore, are composed by two isoprene units [4].
Essential oils are distilled from different parts of the plants including flowers, stem-bark, seeds, leaves, roots, and the whole herbs. They are used to give flavor to foods and drinks and as fragrances in the food and cosmetics industries, where numerous herbal plant and spice ingredients are components in the manufacture of skin creams, lip balms, shampoos, soaps and perfumes.

2. Methodology

The present study was carried out based on the literature review of plants and their essential oils with anticonvulsant activity. All the information about 30 species with anticonvulsant activity is given in Table 1. The list of plants is organized by family and botanical name, parts used and pharmacological activity, as described in the literature. Compounds isolated and references are also provided. The scientific names of the plants were based on W3Tropicos Database (http://mobot.mobot.org/W3T/Search/vast.html), and the abbreviations of author names are according to Brummitt and Powell [5].
The plant species presented here were selected based on the effects shown by their essential oils in specific animal models used for evaluation of anticonvulsant activity and/or by complementary studies, aimed at elucidating the mechanism(s) of action of the oils or individual components.
The essential oils or the main constituents were deemed to display anticonvulsant activity when they had shown effects in one or more different seizure model, including the maximal electroshock (MES) model, the pentylenetetrazole seizures model (PTZ), the pilocarpine model and the prolonged PTZ-kindling model.
Some scientific publications that were excluded from this study because it was not possible to access their full text or because their abstracts were in a language different from English, included the following species, citing their psychopharmacological activities: Apium graveolens Cham., Aralia continentalis Kitag., Asarum heterotropoides F. Schmidt, Asarum himalaicum Hook. F. & Thomson ex Klotzsch, Asarum ichangense C.Y. Cheng & C. S. Yang, Cumimum cyminum L, Eugenia uniflora L, Gardenia augusta (L) Merr., Gardenia jasminoides J. Ellis, Ligusticum sinense Oliv., Ocimum basilicum L. Oplopanax elatus, Radix bupleuri and Salvia sclarea.

3. Results and Discussion

The plant diversity with confirmed activities in the central nervous system is dominated by higher plants, mainly by dicotyledons. In this review 30 species belonging to 13 families and 23 genera have been reported to possess anti-seizure activity.
The families in decreasing order of predominance of species with activity are Myrtaceae and Lamiaceae with five species each; Apiaceae with four species; Asteraceae and Poaceae with three species each and Araceae and Lauraceae with two species each. Six families, corresponding to 46 % of the total, are represented by only one species. Some of these species have other biological activities and are used for different purposes, like Egletes viscosa (L.) Less [6], also mentioned for their antimicrobial activity.
The predominance of higher plants used for medicinal purposes confirms the results obtained in other ethno-medicinal surveys reported by Agra [7,8]. This has also been documented by authors in different countries around the world such as Brazil [9], Saudi Arabia [10], Bolivia [11] or Italy [12], inter alia.
Several aromatic species had been employed since ancient times for their medicinal properties and also as aromatic agents and to give flavor to foods. The pharmacological uses of the plants are mainly attributed to their essential oils having a great variety of pharmacological activities such as prevention and treatment of cancer, against cardiovascular diseases and diabetes. They are also used as sources of gastro-protective, anti-inflammatory, antioxidant, and antibacterial agents. These varied effects are probably due to the high structural diversity of the essential oil constituents. The study of each individual chemical component is critical to understanding its mechanism of pharmacological action and toxicity, including potentially beneficial clinical effects on human health.
However, according to Lahlou [13], the diversity of biological activities presented by the same essential oil has also stimulated discordance between researchers. Many reasons have been proposed for this variability, for example: (a) all the factors that have influence in the chemical composition; (b) the plant’s state of maturation; and (c) the chemotypic difference, among others.
It is accepted that a refined assessment of the chemical composition of tested essential oils/constituents should be performed using GC/MS to perform a quantitative analysis, which would provides additional information of their contents and, consequently, confirmation of their therapeutic effects.
Thirty anticonvulsant chemical constituents of essential oils were mentioned. Most of these compounds are monoterpenes or phenylpropanoids (Figure 1). They are effective in several experimental models of seizure. These constituents must contribute to the anticonvulsant activity of bioactive essential oils, as presented in Table 1. This pharmacological activity may be due to action of a major component or the effect of various bioactive components found in essential oil.
Table 1. Species and respective essential oils that showed anticonvulsant activity organized by botanical family, botanical name, part used, activity as described in the literature, compound isolated and references.
Table 1. Species and respective essential oils that showed anticonvulsant activity organized by botanical family, botanical name, part used, activity as described in the literature, compound isolated and references.
FAMILY SpeciesPART USEDACTIVITY OF ESSENTIAL OILS (as described in the literature)MAIN COMPOUNDS ISOLATED/REFS.
APIACEAE
Cuminum cyminum Linn. (syn. Cuminum odorum Salisb) FruitsThe oil showed protection against pentylenetetrazole-induced epileptic activity by increasing the duration, decreasing the amplitude of after hyperpolarization potential (AHP) following the action potential, the peak of action potential, and inhibition of the firing rate.[14]
Ferula gumosa Boiss. FruitsThe essential oil protected mice against pentylenetetrazole-induced tonic seizures. The protective dose produced neurotoxicity. Moreover, this dose was too close to the LD50 of the essential oil. The anticonvulsant and toxic effects of the essential oil may be related to the compounds pinene and α-thujene respectively. Pinene andα-thujene [15]
Heracleum crenatifolium FruitsThe essential oil protected mice against maximal electroshock (MES)-induced seizures.Octyl acetate and octanol [16]
Pimpinella anisum L. FruitsInhibitor of tonic convulsions induced by high doses of pentylenetetrazole and electroshock trans-corneal. [17]
ARACEAE
Acorus calamus L. Not availableAnticonvulsant action against experimental electroshock. Neither essential oil nor diphenylhydantoin were effective in modifying convulsions produced by metrazole.[18]
Acorus gramineus Aiton RhizomesInhibited the specific bindings of a use-dependent NMDA receptor-ion. Neuroprotective effects on cultured cortical neurons through the blockade of NMDA receptor activity.[19]
RhizomesAnticonvulsant effects, both Acorus gramineus and α-asarone can enhance the reactivity and convulsive threshold of immature rats to electric stimulation. α-asarone [20]
RhizomesPre-inhalation of the oil markedly delayed the appearance of pentylene-tetrazole-induced convulsion. Furthermore, inhalation impressively inhibited the activity of gamma-aminobutyric acid (GABA) trans-aminase, a degrading enzyme for GABA as the inhalation period was lengthened. The GABA level was significantly increased and glutamate content was significantly decreased in mouse brain by pre-inhalation of the essential oil. [21]
Acorus tatarinowii Schott. RhizomesThe volatile oil (1.25 g/kg) decreased the convulsive rate significantly in the maximal electroshock model. But failed to prevent seizures in the dose range tested, although prolonged seizure latency and decreased mortality were found at a dose of 1.25 g/kg. The oil can prevent convulsions as well as convulsion-related GABAergic neuron damage in the brain in the prolonged pentylenetetrazol kindling model.[22]
ASTERACEAE
Artemisia annua L. Fresh leavesThe essential oil (AEO) obtained by hidrodestilation increased the latency time to convulsions induced by picrotoxin and pilocarpine but prevented the onset of pentylenotetrazol and strychnine induced seizures.[23]
Artemisia dracunculus L. Aerial partsThe oil exerted dose and time-dependent antiseizure activity reported in both maximal electroshock and pentylenetetrazole models.trans-Anethole, α-trans-ocimene, limonene, α-pinene, cymene, eugenol, β-pinene, α-terpinolene, bornyl acetate, and bicyclogermacrene [24]
Egletes viscosa (L.) Less. InflorescencesActivity against convulsion induced by PTZ in mice.[6]
EUPHORBIACEAE
Croton zehntneriPax & K. Hoffm. Not availableElevation of the threshold for starting a minimal convulsions induced by pentylenetetrazol.[25]
FABACEAE-MIMOSOIDEAE
Tetrapleura tetraptera(Schumach. & Thonn.) Taub. FruitsInhibitor of convulsions induced by PTZ and electroshocking in mice of both sex.[26]
Fresh fruitsThe fresh oil given intraperitoneally offers some protection against leptazol-induced convulsions. A dose of 0.4 ml of the oil per mouse protected 78% of the animals when administered 30 min prior to leptazol[27]
LAMIACEAE
Aeollanthus suaveolens Mart. ex Spreng. Not availableInhibitor effect of convulsions induced by pentylenetetrazol and maximal electroshock in mice Linalool[28]
LeavesThe anticonvulsant properties of γ-decanolactone was observed in mice. The neurochemical essay with linalool in cortical membranes of rats showed a dose-dependent, not competitive of binding of [3H] MK 801 – an antagonist of receptor NMDA. Also observed the effects of linalool on glutamatergic system in the rat cerebral cortex and that linalool modifies the nicotinic receptor – ion channel kinetics at the mouse neuromuscular junction.γ-Decanolactone and linalool [29,30,31,32]
Not availableThe oil has an inhibitory effect of linalool on glutamate binding in rat cortex was observed. Linalool [30]
Not availableSedative properties on mice and has dose-dependent marked effects on the central nervous system, including hypnotic, anticonvulsant and hypothermic activityγ-Decanolactone [29]
Not availableAn inhibitory effect of linalool on the acetylcholine (ACh) release and on the channel open time in the mouse neuromuscular junction. Linalool [31]
Hyptis suaveolens (L.) Poit. LeavesAnti-convulsive in tests induced by pentylenetetrazol and electroshock in rats of both sex[26]
Lavandula stoechas L. Not available Used as inhalator showed anti-convulsive activity similar to the above. Moreover, was verified a higher level of latency and a reduction of level of the severity of convulsions. Complementary test suggest this activity maybe is related with the blocking of canals of calcium. The inhaling lavender oil vapor blocked pentylene-tetrazole- and nicotine-induced convulsion and electroshock convulsion in mice.[33]
Ocimum gratissimum L. Not availableEssential oil obtained in Spring was able to protect animals against tonic seizures induced by electroshock (MES, 50 mA, 0.11 s). Eugenol [34]
Ocimum basilicum Aerial partWhen tested in mice, the essential oil, higher doses, produced significantly increased in a dose-dependent manner the latency of convulsion and percent of animals exhibiting clonic seizures. Likewise, it reduced lethality in response to different convulsive stimulus used in this study. [35]
Ocimum basilicum LeavesEssential oil increased the latency for development of convulsions in pentylenetetrazol and PIC tests. For pentylenetetrazol, the effects of EO were reversed by flumazenil. EO did not interfered with the convulsions induced by strychnine.1.8-Cineole, linalool, and geraniol were the main components, comprising 92.9% of the oil. [36]
Not availableEssential oil blocked the clonic seizures induced by pentylenetetrazole, picrotoxin and strychnine[37]
LAURACEAE
Laurus nobilis L. LeavesAnticonvulsant activity was observed against pentylenetetrazole- and maximal electroshock-induced seizures. At anticonvulsant doses, the essential oil produced sedation and motor impairment. Methyleugenol, eugenol and pinene [38]
Myristica fragrans SeedNutmeg oil was found to possess significant anticonvulsant activity against electroshock-induced hind limb tonic extension. It exhibited dose dependent anticonvulsant activity against pentylenetetrazole-induced tonic seizures. It delayed the onset of hind limb tonic extensor jerks induced by strychnine. Also it was anticonvulsant at lower doses, whereas weak proconvulsant at a higher dose against pentylenetetrazole and bicuculline induced clonic seizures.[39]
MYRTACEAE
Eucalyptus citriodora Hook LeavesNot availableCitronellal, citronellol, and citronellyl acetate [40]
Eucalyptus urophylla LeavesThe oil increased the number of mice protected against pentylenetetrazole-induced death[41]
Eucalyptus camaldulensis var. camaldulensis Dehn. LeavesNot availablep-Cymene, spathulenol, cryptone, thymol, and linalool [42]
Syzygium aromaticum (L.) Merr. & L.M. Perry=Eugenia caryophyllata Thunb. FlowersInhibition of tonic convulsions induced by electroshock in rats[43]
Psidium persoonii McVaugh=Psidium guianensePers. LeavesThe doses of 100, 200, and 400 mg/kg, by via oral reduced as dose-dependent the severity of convulsions induced by pentylenetetrazole. Moreover, induced the depressor effect of spontaneous movement.[44,45,46]
POACEAE
Cymbopogon winterianusJowitt LeavesAnticonvulsant activity was observed in pentylenetetrazole, pilocarpine, and strychnine tests. Anticonvulsant effect was blocked by flumazenil in pentylenetetrazole model.The EO showed presence of geraniol, citronellal, and citronellol as the main compounds. [47], [48]
Cymbopogon citratus(DC)Stapf LeavesAnticonvulsant activity was observed in pentylenetetrazole, pilocarpine, strychnine, and maximal electroshock tests.[47], [49]
Cymbopogon proximus PlantAdministration of the oil to mice before induction of convulsions with electroshock, resulted in complete protection. There was partial protection in pentylenetetrazole, picrotoxin and strychnine tests.Piperitone, elemol, and eudesmol. [50]
RANUNCULACEAE
Nigella sativaL. Not availableThe oil was the most effective in preventing pentylenetetrazole-induced seizures relative to valproate; also showed significantly decreased oxidative injury in the mouse brain tissue in comparison with the pentylenetetrazole-kindling groupThymoquinone [51]
RUTACEAE
Citrus aurantium L. Peel from fruitsEO from peel increased the latency period of tonic seizures in pentylenetetrazol and maximal electroshock models. Effect was not dose-dependent [52]
VALERIANACEAE
Nardostachys jatamansi (D. Don) DC.Not availableA ketonic principle, jatamansone, isolated from oil of N. jatamansi, is more effective than quinidine and essential oil of jatamansi in suppression of ectopic ventricular activity in unanesthetized dogs produced by 2-stage coronary ligation, equal to quinidine in combating auricular flutter induced by injury stimulation, and more effective than Na diphenyl-hydantoin and essential oil of jatamansi in maximal electroshock seizures.Jatamansone [53]
VERBENACEAE
Lippia alba (Mill.) N.E. Brown. Not availableThe anticonvulsive effects of the essential oils (EOs) from three chemotypes of Lippia alba was observed. The animals were treated with citral (100 mg/kg, i.p.), α-myrcene or limonene (200 mg/kg, i.p.), EOs chem. constituents, presented significant increases in the latency of convulsion and percentage of survival. The association of EOs with diazepam significantly potentiated their effects, suggesting a similar mechanism of action.Citral β-myrceneLimonene [54]
Figure 1. Anticonvulsant chemical constituents of essential oils.
Figure 1. Anticonvulsant chemical constituents of essential oils.
Molecules 16 02726 g001
Considering the thirty species selected in this study, anticonvulsant effect was observed in twenty four of them using the PTZ model. The prevention of seizures induced by PTZ in laboratory animals is the principal protocol used to characterize a potential anticonvulsant drug. The PTZ test represents a valid model for human generalized myoclonic seizures and also by the absence of seizures. On other hand, seventeen species showed anticonvulsant effect by blocking tonic convulsions induced by MES. This test is considered to be a predictor of anti-epileptic drug activity against generalized tonic-clonic seizures.
The more frequent studies involved substances tested via an intraperitoneal route. However, essential oils of Acorus gramineus Aiton and Lavandula stoechas L. only showed anticonvulsant activity when administered by inhalation. This pharmacological result is very interesting as it represents a non invasive route. In a recent review, Edris [55] also presented some comments about the effects of substances administered by inhalation. Additionally, have been suggestions that the inhibitory effect on the central nervous system occurs via gamma-aminobutyric acid (GABA)-ergic neuromodulation system.
The anticonvulsant effect of the main chemical constituents of essential oils (Figure 1) have also been studied. The natural abundance of these compounds allowed systematic studies on their pharmacological properties. Most studies report antiseizure activity of these compounds in animal models of convulsion. The results showed that common essential oil constituents such as terpinen-4-ol [56,57], citral, β-myrcene, limonene [53,58], safranal [59,60], linalool [27,61], γ-decanolactone [28,62], α-terpineol [63], (-)-isopulegol [64], citronellol [65], thymoquinone [66], α,β-epoxycarvone [67], (S)-(+)-carvone [68], eugenol, methyleugenol, isoeugenol, estragole, safrole [69], trans-anethole [70], (-)-borneol and carvacrol [58] are all bioactive in experimental models. Interesting, (R)-(-)-carvone had no anticonvulsant effect. The study showed that the chiral center at carbon 4 in the carvone molecule is important in the interaction with the receptor. The molecule with isopropenyl group in S configuration at carbon 4 is clearly capable of reducing the convulsive effect of PTZ and PIC in terms of onset time. A comparative analysis of the constituents cannot however be done due to the different experimental conditions and variability of methods and routes of administration used in the evaluation of these compounds.
Anticonvulsant activity was also identified in some sesquiterpenes such as valeranone [52] and β-eudesmol [71]. Others compounds found in essential oils also showed this effect. For example, some phthalides such as butylidenephthalide, ligustilide, butylphthalide, neocnidilide, and senkyunolide [72]. α-Asarone, a phenylpropanoid, also presented effective anticonvulsant activity [19].
The present study reports a limited number of plant species based on a set of papers which the molecular mechanisms of anticonvulsant action of the volatile oils/constituents was possible to investigate. Of these, two species are prominent, Acorus gramineus Aiton and Aeollanthus suaveolens Mart. ex Spreng, belonging to the Araceae and Lamiaceae families, respectively.
The activity of Acorus gramineus was suggested by the essential oil having anticonvulsant effect through the blockade of NMDA receptor. On other hand, the psychopharmacological effect of Aeollanthus suaveolens was attributed to the monoterpene compound linalool, reported to be a major component of essential oils in several aromatic plants, including this species. Recent findings provide evidence that the anticonvulsant effects of monoterpenes could be modulated by Ach mechanisms. Moreover, other studies suggest a direct interaction with the NMDA receptor complex [31].

4. Conclusions

In conclusion, the thirty aromatic species, listed in the present paper and represented by their essential oils/chemical constituents, appear to be promissory as sources of anticonvulsant agents. Thirty anticonvulsant chemical constituents of essential oils also were related. Nevertheless, the data show that most chemical classes of compounds found in essential oils are effective in convulsion models. They must act by different mechanisms of action that merit further investigation. The future outlook for the development of new antiepileptic drugs derived from essential oils is therefore positive.

Acknowledgements

This research was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Apoio a Pesquisa e Inovação Tecnológica do Estado de Sergipe (FAPITEC).

References

  1. WHO. The World Health Report. Mental Health: New Understanding New Hope; WHO: Geneva, Switzerland, 2001.
  2. Sander, J.W.; Shorvon, S.D. Epidemiology of the epilepsies. J. Neurol. Neurosurg. Psychiat. 1996, 61, 433–443. [Google Scholar] [CrossRef]
  3. Almeida, R.N.; Motta, S.C.; Leite, J.R. Óleos essenciais com propriedades anticonvulsivantes. Bol. Latinoam. Caribe Plant. Med. Aromat. 2003, 2, 3–6. [Google Scholar]
  4. Craveiro, A.A.; Fernandes, A.G.; Andrade, C.H.S.; Matos, F.J.A.; Alencar, J.W.; Machado, M.I.L. Óleos Essenciais de Plantas do Nordeste; Edições UFC: Fortaleza, Brazil, 1981. [Google Scholar]
  5. Brummitt, R.K.; Powell, C.E. Authors of Plant Names; Royal Botanic Gardens: Kew, UK, 1992; p. 732. [Google Scholar]
  6. Souza, M.F.; Santos, F.A.; Rao, V.S.N.; Sidrin, J.J.C.; Matos, F.J.A.; Machedo, M.I.L.; Silveira, E.R. Antinociceptive, anticonvulsant and antibacterial effects of the essential oil from the flower heads of Egletes viscosa L. Phytother. Res. 1998, 12, 28–31. [Google Scholar] [CrossRef]
  7. Agra, M.F.; Baracho, G.S.; Nurit, K.; Basílio, I.J.L.D.; Coelho, V.P.M. Medicinal and poisonous diversity of the flora of "Cariri Paraibano'', Brazil. J. Ethnopharmacol. 2007, 111, 383–395. [Google Scholar] [CrossRef]
  8. Agra, M.F.; Freitas, P.F.; Barbosa-Filho, J.M. Synopsis of the plants known as medicinal and poisonous in Northeast of Brazil. Rev. Bras. Farmacogn. 2007, 17, 114–140. [Google Scholar] [CrossRef]
  9. Mendes, F.R.; Carlini, E.A. Brazilian plants as possible adaptogens: An ethnopharmacological survey of books edited in Brazil. J. Ethnopharmacol. 2006, 109, 493–500. [Google Scholar]
  10. Rahman, M.A.; Mossa, J.S.; Al-Said, M.S.; Al-Yahya, M.A. Medicinal plant diversity in the flora of Saudi Arabia 1: A report on seven plant families. Fitoterapia 2004, 75, 149–161. [Google Scholar] [CrossRef]
  11. Macía, M.J.; García, E.; Vidaurre, P.J. An ethnobotanical survey of medicinal plants commercialized in the markets of La Paz and El Alto, Bolivia. J. Ethnopharmacol. 2005, 97, 337–350. [Google Scholar] [CrossRef]
  12. Scherrer, A.M.; Motti, R.; Weckerle, C.S. Traditional plant use in the areas of Monte Vesole and Ascea, Cilento National Park (Campania, Southern Italy). J. Ethnopharmacol. 2005, 97, 129–143. [Google Scholar] [CrossRef]
  13. Lahlou, M. Methods to study the phytochemistry and bioactivity of essential oils. Phytother. Res. 2004, 18, 435–448. [Google Scholar] [CrossRef]
  14. Janahmadi, M.; Niazi, F.; Danyali, S.; Kamalinejad, M. Effects of the fruit essential oil of Cuminum cyminum Linn. (Apiaceae) on pentylenetetrazol-induced epileptiform activity in F1 neurones of Helix aspersa. J. Ethnopharmacol. 2006, 104, 278–282. [Google Scholar] [CrossRef]
  15. Sayyah, M.; Kamalinejad, M.; Hidage, R.B.; Rustaiyan, A. Antiepileptic potential and composition of the fruit essential oil of Ferula gummosa boiss. Iran Biomed. J. 2001, 5, 69–72. [Google Scholar]
  16. Tosun, F.; Kizilay, C.A.; Erol, K.; Kilic, F.S.; Kurkcuoglu, M.; Baser, K.H.C. Anticonvulsant activity of furanocoumarins and the essential oil obtained from the fruits of Heracleum crenatifolium. Food Chem. 2008, 107, 990–993. [Google Scholar] [CrossRef]
  17. Pourgholami, M.H.; Majzoob, S.; Javadi, M.; Kamalinejad, M.; Fanacee, G.H.R.; Sayyah, M. The fruit essential oil of Pimpinella anisum exerts anticonvulsant effect in mice. J. Ethnopharmacol. 1999, 66, 211–215. [Google Scholar] [CrossRef]
  18. Madan, B.R.; Arora, R.B.; Kapila, K. Anticonvulsant, antiveratrinic, and antiarrhythmic actions of Acorus calamus, an Indian indigenous drug. Arch. Int. Pharmacodyn. Ther. 1960, 124, 201–211. [Google Scholar]
  19. Cho, J.; Kong, J.-Y.; Jeong, D.-Y.; Lee, K.D.; Lee, D.-U.; Kang, B.-S. NMDA receptor-mediated neuroprotection by essential oils from the rhizomes of Acorus gramineus. Life Sci. 2001, 68, 1567–1573. [Google Scholar] [CrossRef]
  20. Yang, L.; Li, S.; Wang, Y.; Huang, Y. Effects of Acorus gramineus and its main component alpha-asarone on the reactivity and convulsive threshold of immature rats to electric stimulation. Neural Regen. Res. 2006, 1, 78–80. [Google Scholar]
  21. Koo, B.-S.; Park, K.-S.; Ha, J.-H.; Park, J.H.; Lim, J.-C.; Lee, D.-U. Inhibitory effects of the fragrance inhalation of essential oil from Acorus gramineus on central nervous system. Biol. Pharm. Bull. 2003, 26, 978–982. [Google Scholar] [CrossRef]
  22. Liao, W.-P.; Chen, L.; Yi, Y.-H.; Sun, W.-W.; Gao, M.-M.; Su, T.; Yang, S.-Q. Study of antiepileptic effect of extracts from Acorus tatarinowii Schott. Epilepsia 46 Suppl. 1, 21–24.
  23. Perazzo, F.F.; Carvalho, J.C.T.; Carvalho, J.E.; Rehder, V.L.G. Central properties of the essential oil and the crude ethanol extract from aerial parts of Artemisia annua L. Pharmacol. Res. 2003, 48, 497–502. [Google Scholar] [CrossRef]
  24. Sayyah, M.; Nadjafnia, L.; Kamalinejad, M. Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil. J. Ethnopharmacol. 2004, 94, 283–287. [Google Scholar]
  25. Batatinha, M.J.M.; de Souza, S.H.; Bernardi, M.M. Croton zehntneri: Possible central nervous system effects of the essential oil in rodents. J. Ethnopharmacol. 1995, 45, 53–57. [Google Scholar] [CrossRef]
  26. Akah, P.A.; Nwambie, A.I. Nigerian plants with anticonvulsant property. Fitoterapia 1993, 64, 42–44. [Google Scholar]
  27. Nwaiwu, J.I.; Akah, P.A. Anticonvulsant activity of the volatile oil from the fruit of Tetrapleura tatraptera. J. Ethnopharmacol. 1986, 18, 103–107. [Google Scholar] [CrossRef]
  28. Elisabetsky, E.; De Souza, G.P.C.; Santos, M.A.C.; Siqueira, I.R.; Amador, T.A.; Nunes, D.S. Sedative properties of linalool. Fitoterapia 1995, 66, 407–414. [Google Scholar]
  29. Coelho de Souza, G.P.; Elisabetsky, E.; Nunes, D.S.; Rabelo, S.K.L.; Silva, M.N. Anticonvulsant properties of γ-decanolactone in mice. J. Ethnopharmacol. 1997, 58, 175–181. [Google Scholar] [CrossRef]
  30. Elisabetsky, E.; Marschner, J.; Souza, D.O. Effects of linalool on glutamatergic system in the rat cerebral cortex. Neurochem. Res. 1995, 20, 461–465. [Google Scholar] [CrossRef]
  31. Re, L.; Barocci, S.; Sonnino, S.; Mencarelli, A.; Vivan, C.; Paolucci, G.; Scarpantonio, A.; Rinaldi, L.; Mosca, E. Linalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction. Pharmacol. Res. 2000, 42, 177–181. [Google Scholar] [CrossRef]
  32. Brum, L.F.S.; Elisabetsky, E.; Souza, D. Effects of linalool on [3H] MK801 and [3H] muscimol binding in mouse cortical membranes. Phytother. Res. 2001, 15, 422–425. [Google Scholar] [CrossRef]
  33. Yamada, K.; Mimaki, Y.; Sashida, Y. Anticonvulsive effects of inhaling lavender oil vapor. Biol. Pharm. Bull. 1994, 17, 359–360. [Google Scholar] [CrossRef]
  34. Freire, C.M.M.; Marques, M.O.M.; Costa, M. Effects of seasonal variation on the central nervous system activity of Ocimum gratissimum L. essential oil. J. Ethnopharmacol. 2006, 105, 161–166. [Google Scholar] [CrossRef]
  35. Ismail, M. Central properties and chemical composition of Ocimum basilicum essential oil. Pharm. Biol. 2006, 44, 619–626. [Google Scholar] [CrossRef]
  36. Oliveira, J.S.; Porto, L.A.; Estevam, C.S.; Siqueira, R.S.; Alves, P.B.; Niculau, E.S.; Blank, A.F.; Almeida, R.N.; Marchioro, M.; Quintans-Junior, L.J. Phytochemical screening and anticonvulsant property of Ocimum basilicum leaf essential oil. Bol. Latinoam. Caribe Plant. Med. Aromat. 2009, 8, 195–202. [Google Scholar]
  37. Farag, M.M. Antioxidant and anticonvulsant activities of some volatile oils. J. Drug Res. 2005, 26, 38–45. [Google Scholar]
  38. Sayyah, M.; Valizadeh, J.; Kamalinejad, M. Anticonvulsant activity of the leaf essential oil of Laurus nobilis against pentylenetetrazole- and maximal electroshock-induced seizures. Phytomedicine 2002, 9, 212–216. [Google Scholar] [CrossRef]
  39. Wahab, A.; Haq, R.U.; Ahmed, A.; Khan, R.A.; Raza, M. Anticonvulsant activities of nutmeg oil of Myristica fragrans. Phytother. Res. 2009, 23, 153–158. [Google Scholar] [CrossRef]
  40. El-Zalabani, S.M.; Koheil, M.M.; Meselhy, K.M.; El-Gizawy, H.A.; Sleem, A.A. Effect of seasonal variation on composition and bioactivities of the essential oil of Eucalyptus citriodora Hook grown in Egypt. Egypt. J. Biomed. Sci. 2007, 24, 260–276. [Google Scholar]
  41. Teixeira, G.F.D.; Lima, R.C.P., Jr.; Silveira, E.R.; Freitas, M.O.; Campos, A.R. Sedative effect of Eucalyptus urophylla and E. brassiana in mice. Nat. Prod. Commun. 2008, 3, 1539–1542. [Google Scholar]
  42. El Zalabani, S.M.; Koheil, M.M.; Meselhy, K.M.; El-Gizawy, H.A.; Sleem, A.A. The influence of seasonal variation on composition and bioactivities of the essential oil of Eucalyptus camaldulensis var. camaldulensis Dehn. grown in Egypt. Bull. Fac. Pharm. Cairo Univ. 2008, 46, 167–180. [Google Scholar]
  43. Pourgholami, M.H.; Kamalinejad, M.; Javadi, M.; Majzoob, S.; Sayyah, M. Evaluation of anticonvulsant activity of essential oil of Eugenia caryophyllata in male mice. J. Ethnopharmacol. 1999, 64, 167–171. [Google Scholar] [CrossRef]
  44. Leal-Cardoso, J.H.; Fonteles, M.C. Pharmacological effects of essential oils of plants of the Northeast of Brazil. A. Ac. Br. Ciên. 1999, 71, 207–213. [Google Scholar]
  45. Santos, F.A.; Rao, V.S.; Silveira, E.R. The leaf essential oil of Psidium guyanensis offers protection against pentylenetetrazole-induced seizures. Planta Med. 1997, 63, 133–135. [Google Scholar] [CrossRef]
  46. Santos, F.A.; Rao, V.S.; Silveira, E.R. Studies on the neuropharmacological effects of Psidium guyanensis and Psidium pohlianum essential oils. Phytother. Res. 1996, 10, 655–658. [Google Scholar] [CrossRef]
  47. Silva, M.R.; Ximenes, R.M.; Costa, J.G.M.; Leal, L.K.A.M.; Lopes, A.A.; Viana, G.S.B. Comparative anticonvulsant activities of the essential oils (EOs) from Cymbopogon winterianus Jowitt and Cymbopogon citratus (DC) Stapf. in mice. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 381, 415–426. [Google Scholar] [CrossRef]
  48. Quintans-Junior, L.J.; Souza, T.T.; Leite, B.S.; Lessa, N.M.N.; Bonjardim, L.R.; Santos, M.R.V.; Alves, P.B.; Blank, A.F.; Antoniolli, A.R. Phythochemical screening and anticonvulsant activity of Cymbopogon winterianus Jowitt (Poaceae) leaf essential oil in rodents. Phytomedicine 2008, 15, 619–624. [Google Scholar] [CrossRef]
  49. Blanco, M.M.; Costa, C.A.R.A.; Freire, A.O.; Santos, J.G., Jr.; Costa, M. Neurobehavioral effect of essential oil of Cymbopogon citratus in mice. Phytomedicine 2009, 16, 265–270. [Google Scholar] [CrossRef]
  50. El Tahir, K.E.H.; Abdel-Kader, M.S. Chemical and pharmacological study of Cymbopogon proximus volatile oil. Res. J. Med. Plant 2008, 2, 53–60. [Google Scholar] [CrossRef]
  51. Ilhan, A.; Gurel, A.; Armutcu, F.; Kamisli, S.; Iraz, M. Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacol. 2005, 49, 456–464. [Google Scholar] [CrossRef]
  52. Carvalho-Freitas, M.I.R.; Costa, M. Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. Biol. Pharm. Bull. 2002, 25, 1629–1633. [Google Scholar] [CrossRef]
  53. Arora, R.B.; Sharma, P.L.; Kapila, K. Antiarrhythmic and anticonvulsant activity of jatamansone. Indian J. Med. Res. 1958, 46, 782–791. [Google Scholar]
  54. Viana, G.S.B.; Do Vale, T.G.; Silva, C.M.M.; Matos, F.J.A. Anticonvulsant activity of essential oils and active principles from chemotypes of Lippia alba (MILL.) N.E. Brown. Biol. Pharm. Bull. 2000, 23, 1314–1317. [Google Scholar] [CrossRef]
  55. Edris, A.E. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytother. Res. 2007, 21, 308–323. [Google Scholar] [CrossRef]
  56. Atanasova-Shopova, S.; Rusinov, K.S.; Boicheva, I. Central neurotropic effects of lavender essential oil. Bulgarska Akademiya na Naukite 1973, 15, 149–156. [Google Scholar]
  57. De Sousa, D.P.; Nobrega, F.F.F.; de Morais, L.C.S.L.; de Almeida, R.N. Evaluation of the anticonvulsant activity of terpinen-4-ol. Z. Naturforsch. C 2009, 64, 1–5. [Google Scholar]
  58. Quintans-Junior, L.J.; Guimarães, A.G.; Araujo, B.E.S.; Oliveira, G.F.; Santana, M.T.; Moreira, F.V.; Santos, M.R.V.; Cavalcanti, S.C.H.; De Lucca, W., Jr.; Botelho, M.A.; Ribeiro, L.A.A.; Nobrega, F.F.F.; Almeida, R.N. Carvacrol, (-)-borneol and citral reduce convulsant activity in rodent. Afr. J. Biotechnol. 2010, 9, 6566–6572. [Google Scholar]
  59. Hosseinzadeh, H.; Talebzadeh, F. Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia 2005, 76, 722–724. [Google Scholar] [CrossRef]
  60. Pathan, S.A.; Zaidi, S.M.A.; Jain, G.K.; Vohora, D.; Ahmad, F.J.; Khar, R.K. Anticonvulsant evaluation of safranal in pentylenetefrazole-induced status epilepticus in mice. Int. J. Essen. Oil Ther. 2009, 3, 106–108. [Google Scholar]
  61. De Sousa, D.P.; Nóbrega, F.F.F.; Santos, C.C.M.P.; De Almeida, R.N. Anticonvulsant Activity of the Linalool Enantiomers and Racemate: Investigation of the Chiral Influence. Nat. Prod. Commun. 2010, 5, 1847–1851. [Google Scholar]
  62. Oliveira, P.A.; Lino, F.L.; Cappelari, S.E.; Brum, L.F.S.; Picada, J.N.; Pereira, P. Effects of gamma-decanolactone on seizures induced by PTZ-kindling in mice. Exp. Brain Res. 2008, 187, 161–166. [Google Scholar] [CrossRef]
  63. De Sousa, D.P.; Quintans, L., Jr.; de Almeida, R.N. Evolution of the anticonvulsant activity of α-terpineol. Pharm. Biol. 2007, 45, 69–70. [Google Scholar] [CrossRef]
  64. Silva, M.I.G.; Silva, M.A.G.; Neto, M.R.A.; Moura, B.A.; De Sousa, H.L.; De Lavor, E.P.H.; De Vasconcelos, P.F.; Macedo, D.S.; De Sousa, D.P.; Vasconcelos, S.M.M.; De Sousa, F.C.F. Effects of isopulegol on pentylenetetrazol-induced convulsions in mice: Possible involvement of GABAergic system and antioxidant activity. Fitoterapia 2009, 80, 506–513. [Google Scholar] [CrossRef]
  65. De Sousa, D.P.; Goncalves, J.C.R.; Quintans-Junior, L.; Cruz, J.S.; Araujo, D.A.M.; De Almeida, R.N. Study of anticonvulsant effect of citronellol, a monoterpene alcohol, in rodents. Neurosci. Lett. 2006, 401, 231–235. [Google Scholar] [CrossRef]
  66. Hosseinzadeh, H.; Parvardeh, S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine 2004, 11, 56–64. [Google Scholar] [CrossRef]
  67. De Almeida, R.N.; De Sousa, D.P.; Nobrega, F.F.F.; Claudino, F.S.; Araujo, D.A.M.; Leite, J.R.; Mattei, R. Anticonvulsant effect of a natural compound α, β-epoxy-carvone and its action on the nerve excitability. Neurosci. Lett. 2008, 443, 51–55. [Google Scholar] [CrossRef]
  68. De Sousa, D.P.; Nobrega, F.F.F.; De Almeida, R.N. Influence of the chirality of (R)-(-)- and (S)-(+)-carvone in the central nervous system: A comparative study. Chirality 2007, 19, 264–268. [Google Scholar] [CrossRef]
  69. Dallmeier, K.; Carlini, E.A. Anesthetic, hypothermic, myorelaxant and anticonvulsant effects of synthetic eugenol derivatives and natural analogues. Pharmacology 1981, 22, 113–127. [Google Scholar] [CrossRef]
  70. Boissier, J.R.; Simon, P.; Le Bourhis, B. Experimental psychotropic effect of isomeric cis- and trans-anetholes. Therapie 1967, 22, 309–323. [Google Scholar]
  71. Chiou, L.C.; Ling, J.Y.; Chang, C.C. Chinese herb constituent beta-eudesmol alleviated the electroshock seizures in mice and electrographic seizures in rat hippocampal slices. Neurosci. Lett. 1997, 231, 171–174. [Google Scholar] [CrossRef]
  72. Luo, Y.; Pan, J.; Ding, K.; Yan, Z. Anticonvulsive constituents in the essential oil of Chaxiong (Ligusticum sinense Oliv cv. Chaxiong). Zhong Cao Yao 1996, 27, 456–457. [Google Scholar]
  • Sample Availability: Not available.

Share and Cite

MDPI and ACS Style

Nóbrega de Almeida, R.; Agra, M.d.F.; Negromonte Souto Maior, F.; De Sousa, D.P. Essential Oils and Their Constituents: Anticonvulsant Activity. Molecules 2011, 16, 2726-2742. https://doi.org/10.3390/molecules16032726

AMA Style

Nóbrega de Almeida R, Agra MdF, Negromonte Souto Maior F, De Sousa DP. Essential Oils and Their Constituents: Anticonvulsant Activity. Molecules. 2011; 16(3):2726-2742. https://doi.org/10.3390/molecules16032726

Chicago/Turabian Style

Nóbrega de Almeida, Reinaldo, Maria de Fátima Agra, Flávia Negromonte Souto Maior, and Damião Pergentino De Sousa. 2011. "Essential Oils and Their Constituents: Anticonvulsant Activity" Molecules 16, no. 3: 2726-2742. https://doi.org/10.3390/molecules16032726

Article Metrics

Back to TopTop